M H25 (Hydroxyzine 25 mg)
Pill imprint M H25 has been identified as Hydroxyzine hydrochloride 25 mg.
Hydroxyzine is used in the treatment of anxiety; pain; sedation; allergic urticaria; allergies (and more), and belongs to the drug classes antihistamines, miscellaneous anxiolytics, sedatives and hypnotics. FDA has not classified the drug for risk during pregnancy. Hydroxyzine 25 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Imprint:
- M H25
- Strength:
- 25 mg
- Color:
- Blue
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- Antihistamines
Miscellaneous anxiolytics, sedatives and hypnotics - Pregnancy Category:
- N - Not classified
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Mylan Pharmaceuticals Inc.
- National Drug Code (NDC):
- 00378-2587
- Inactive Ingredients:
- lactose anhydrous
silicon dioxide
crospovidone
magnesium stearate
microcrystalline cellulose
polyethylene glycol
polyvinyl alcohol
sodium lauryl sulfate
magnesium silicate
titanium dioxide
FD&C Blue No. 2
| NDC Code | Manufacturer / Repackager |
|---|---|
| 51079-0806 | UDL Laboratories Inc |
Note: Inactive ingredients may vary.
More about hydroxyzine
Consumer resources
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
